Found: 5
Select item for more details and to access through your institution.
Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Is Dolutegravir Plus Atazanavir Overburdened With Concentration-Related Neurological Events Compared With Other Dual Regimens?
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 2, p. N.PAG, doi. 10.1093/ofid/ofz044
- By:
- Publication type:
- Article
Short‐term inhibition of SARS‐CoV‐2 by hydrogen peroxide in persistent nasopharyngeal carriers.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 3, p. 1766, doi. 10.1002/jmv.26485
- By:
- Publication type:
- Article
Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164753
- By:
- Publication type:
- Article
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data.
- Published in:
- 2017
- By:
- Publication type:
- journal article